REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,246,000 | +54.4% | 68,569 | +24.3% | 0.02% | +69.2% |
| Q4 2021 | $1,455,000 | -70.5% | 55,172 | +12.7% | 0.01% | -71.7% |
| Q3 2021 | $4,924,000 | -30.1% | 48,935 | -1.7% | 0.05% | -29.2% |
| Q2 2021 | $7,042,000 | +63.0% | 49,757 | +14.9% | 0.06% | +51.2% |
| Q1 2021 | $4,319,000 | -14.9% | 43,320 | +5.5% | 0.04% | -15.7% |
| Q4 2020 | $5,075,000 | +35.8% | 41,056 | +7.0% | 0.05% | +21.4% |
| Q3 2020 | $3,738,000 | -37.4% | 38,370 | +0.2% | 0.04% | -40.8% |
| Q2 2020 | $5,975,000 | +53.0% | 38,298 | +41.5% | 0.07% | +29.1% |
| Q1 2020 | $3,906,000 | -12.7% | 27,059 | +23.6% | 0.06% | +12.2% |
| Q4 2019 | $4,476,000 | +420.5% | 21,894 | +104.3% | 0.05% | +390.0% |
| Q3 2019 | $860,000 | -14.9% | 10,716 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $1,011,000 | – | 10,716 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |